Zhejiang Medicine Co Ltd Cash Flow Quality Index
Zhejiang Medicine Co Ltd cash flow quality index. Zhejiang Medicine Co Ltd (600216) has a Cash Flow Quality Index of 2.66x as of September 2025. Operating cash flow of CN¥690.77 Million exceeds net income of CN¥259.84 Million, indicating high earnings quality where cash backs reported profits. See Zhejiang Medicine Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Zhejiang Medicine Co Ltd (1998–2025)
Cash flow quality index of Zhejiang Medicine Co Ltd from 1998 to 2025. Historical Cash Flow Quality Index for Zhejiang Medicine Co Ltd across 28 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 600216 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Zhejiang Medicine Co Ltd Cash Flow Quality Index by Year (1998–2025)
Zhejiang Medicine Co Ltd cash flow quality index by year from 1998 to 2025. Year-by-year earnings quality comparison for Zhejiang Medicine Co Ltd. For the full cash flow conversion analysis, see 600216 cash generation efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.16x | CN¥1.89 Billion | CN¥873.38 Million | ▲ +80.1% |
| 2024 | 1.20x | CN¥1.22 Billion | CN¥1.02 Billion | ▼ -18.8% |
| 2023 | 1.48x | CN¥634.31 Million | CN¥429.64 Million | ▲ +2.8% |
| 2022 | 1.44x | CN¥520.60 Million | CN¥362.61 Million | ▲ +11.7% |
| 2021 | 1.29x | CN¥1.14 Billion | CN¥884.56 Million | ▼ -32.6% |
| 2020 | 1.91x | CN¥1.26 Billion | CN¥659.64 Million | ▲ +24.4% |
| 2019 | 1.53x | CN¥447.25 Million | CN¥291.95 Million | ▼ -13.6% |
| 2018 | 1.77x | CN¥579.91 Million | CN¥327.21 Million | ▼ -15.7% |
| 2017 | 2.10x | CN¥503.47 Million | CN¥239.54 Million | ▲ +177.8% |
| 2016 | 0.76x | CN¥336.14 Million | CN¥444.34 Million | ▲ +12.3% |
| 2015 | 0.67x | CN¥106.54 Million | CN¥158.22 Million | ▼ -79.0% |
| 2014 | 3.21x | CN¥549.90 Million | CN¥171.34 Million | ▲ +121.7% |
| 2013 | 1.45x | CN¥655.09 Million | CN¥452.60 Million | ▲ +52.6% |
| 2012 | 0.95x | CN¥807.49 Million | CN¥851.14 Million | ▲ +5.6% |
| 2011 | 0.90x | CN¥912.75 Million | CN¥1.02 Billion | ▼ -21.9% |
| 2010 | 1.15x | CN¥1.32 Billion | CN¥1.14 Billion | ▼ -4.7% |
| 2009 | 1.21x | CN¥1.47 Billion | CN¥1.21 Billion | ▼ -1.7% |
| 2008 | 1.23x | CN¥1.20 Billion | CN¥977.28 Million | ▼ -70.4% |
| 2007 | 4.14x | CN¥227.67 Million | CN¥54.95 Million | ▲ +44.9% |
| 2006 | 2.86x | CN¥169.51 Million | CN¥59.27 Million | ▲ +869.8% |
| 2005 | 0.29x | CN¥25.14 Million | CN¥85.27 Million | ▼ -96.9% |
| 2004 | 9.49x | CN¥107.60 Million | CN¥11.33 Million | ▼ -50.6% |
| 2003 | 19.20x | CN¥66.20 Million | CN¥3.45 Million | ▲ +1347.3% |
| 2002 | 1.33x | CN¥23.13 Million | CN¥17.43 Million | ▼ -79.5% |
| 2001 | 6.48x | CN¥98.25 Million | CN¥15.16 Million | ▲ +1178.3% |
| 2000 | 0.51x | CN¥10.58 Million | CN¥20.87 Million | ▲ +138.4% |
| 1999 | -1.32x | CN¥-51.90 Million | CN¥39.29 Million | ▼ -189.9% |
| 1998 | 1.47x | CN¥57.72 Million | CN¥39.27 Million | — |